The Clinical Evaluation of Patients with Mental Retardation/Intellectual Disability

Genetics of Mental Retardation: An Overview Encompassing Learning Disability and Intellectual Disability

Volumn 18, Issue , 2010, Pages 57-66

  Romano, Corrado ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872494396     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805592819.ch5     Document Type: Chapter

References (43)

1. Croen LA, Grether JK, Selvin S: The epi- demiology of mental retardation of unknown cause. Pediatrics 2001;107:e86.
2. Massey PS, McDermott S: State-specific rates of mental retardation-United States. MMWR 1995;45:61-65.
3. Yeargin-Allsopp M, Murphy CC, Cord- ero JF, Decouflé P, Hollowell JG: Reported biomedical causes and associ- ated medical conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985 to 1987. Dev Med Child Neurol 1997;39:142-149.
4. Kabra M, Gulati S: Mental retardation. Indian J Pediatr 2003;70:153-158.
5. Landgren M, Pettersson R, Kjellman B, Gillberg C: ADHD, DAMP and other neurodevelopmental/psychiatric disor- ders in 6-year-old children: epidemiol- ogy and co-morbidity. Dev Med Child Neurol 1996;38:891-906.
6. Soto-Ares G, Joyes B, Lemaĭtre MP, Vallée L, Pruvo JP: MRI in children with mental retardation. Pediatr Radiol 2003;33:334-345.
7. Battaglia A, Carey JC: Diagnostic evalua- tion of developmental delay/mental retardation: an overview. Am J Med Genet 2003;117C:3-14.
8. Patterson MC, Zoghbi HY: Mental retar- dation. X marks the spot. Neurology 2003;61:156-157.
9. American Psychiatric Association: Diag- nostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision, Ameri- can Psychiatric Association, Washing- ton, 2000, pp 41-49.
10. Sparrow SS, Balla DA, Cicchetti DV: Vineland Adaptive Behavior Scales. Cir- cle Pine, American Guidance Service, 1984.
11. Xu J, Chen Z: Advances in molecular cytogenetics for the evaluation of mental retardation. Am J Med Genet 2003;117C:15-24.
12. Stevenson RE, Procopio-Allen AM, Schroer RJ, Collins JS: Genetic syn- dromes among individuals with mental retardation. Am J Med Genet A 2003;123:29-32.
13. Ramakers GJA: Rho proteins, mental retardation and the cellular basis of cog- nition. Trends Neurosci 2002;25:191- 199.
14. Stevenson RE: Splitting and lumping in the nosology of XLMR. Am J Med Genet 2000;97:174-182.
15. Shevell MI, Ashwal S, Donley D, Flint J, Gingold M, et al: Practice parameter: Evaluation of the child with global devel- opmental delay. Report of the Quality Standards Subcommittee of the Ameri- can Academy of Neurology and the Practice Committee of the Child Neurol- ogy Society. Neurology 2003;60:367- 380.
16. Van Karnebeek CDM, Jansweijer MCE, Leenders AGE, Offringa M, Hennekam RCM: Diagnostic investigations in indi- viduals with mental retardation: a sys- tematic review of their usefulness. Eur J Hum Genet 2005;13:6-25.
17. Battaglia A, Bianchini E, Carey JC: Diag- nostic yield of the comprehensive assess- ment of developmental delay/mental retardation in an institute of child neu- ropsychiatry. Am J Med Genet 1999;82:60-66.
18. Majnemer A, Shevell MI: Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr 1995;127:193-199.
19. Shevell MI, Majnemer A, Rosembaum P, Abrahamowicz M: Etiologic yield of sub- specialists' evaluation of young children with global developmental delay. J Pedi- atr 2000;136:593-598.
20. Slavotinek AM: Novel microdeletion syndromes detected by chromosome microarrays. Hum Genet 2008;124:1-17.
21. Graham SM, Selikowicz M: Chromo- some testing in children with develop- mental delay in whom the aetiology is not evident clinically. J Paediatr Child Health 1993;29:360-362.
22. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, et al: Evaluation of mental retardation: recommendations of a Consensus Conference: American Col- lege of Medical Genetics. Am J Med Genet 1997;72:468-477.
23. Knight SJL, Horsley SW, Regan R, Lawrie NM, Maher EJ, et al: Development and clinical application of an innovative fluo- rescence in situ hybridisation technique which detects submicroscopic rear- rangements involving telomeres. Eur J Hum Genet 1997;5:1-8.
24. Flint J, Knight S: The use of telomere probes to investigate submicroscopic rearrangements associated with mental retardation. Curr Opin Genet Dev 2003;13:310-316.
25. Bodensteiner JB, Schaefer JB: Evaluation of the patient with idiopathic mental retardation. J Neuropsychiatry 1995;7:361-370.
26. Hunter AGW: Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am J Med Genet 2000;90:60-68.
27. De Vries BB, White SM, Knight SJ, Regan R, Homfray T, et al: Clinical stud- ies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet 2001;38:145-150.
28. Aradhya S, Cherry AM: Array-based comparative genomic hybridization: clinical contexts for targeted and whole- genome designs. Genet Med 2007;9:553- 559.
29. Shaffer LG, Bejjani BA, Torchia B, Kirk- patrick S, Coppinger J, Ballif BC: The identification of microdeletion syn- dromes and other chromosomal abnor- malities: cytogenetic methods of the past, new technologies for the future. Am J Med Genet C Semin Med Genet 2007;145:335-345.
30. Shaikh TH: Oligonucleotide arrays for high-resolution analysis of copy number alteration in mental retardation/multiple congenital anomalies. Genet Med 2007;9:617-625.
31. Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, et al: Emerging pat- terns of cryptic chromosomal imbalance in patients with idiopathic mental retar- dation and multiple congenital anoma- lies: a new series of 140 patients and review of published reports. J Med Genet 2006;43:625-633.
32. Shaffer LG, Bejjani BA: Medical applica- tions of array CGH and the transforma- tion of clinical cytogenetics. Cytogenet Genome Res 2006;115:303-309.
33. Veltman JA, De Vries BB: Diagnostic genome profiling: unbiased whole genome or targeted analysis? J Mol Diagn 2006;8:534-537.
34. Stankiewicz P, Beaudet AL: Use of array CGH in the evaluation of dysmorphol- ogy, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 2007;17:182-192.
35. Veltman JA, De Vries BB: Whole- genome array comparative genomic hybridization: the preferred diagnostic choice in post-natal clinical cytogenet- ics. J Mol Diagn 2007;9:277.
36. Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, et al: A new chro- mosome 17q21.31 microdeletion syn- drome associated with a common inver- sion polymorphism. Nat Genet 2006;38:999-1001.
37. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, et al: Microdele- tion encompassing MAPT at chromo- some 17q21.3 is associated with devel- opmental delay and learning disability. Nat Genet 2006;38:1032-1037.
38. Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, et al: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 2006;38:1038-1042.
39. Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJL, et al: Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 2008;45:710-720.
40. De Vries BB, Mohkamsing S, Van Den Ouweland AM, Mol E, Gelsema K, et al: Screening for the fragile X syndrome among the mentally retarded: a clinical study. The collaborative fragile X study group. J Med Genet 1999;36:467-470.
41. Musumeci SA, Colognola RM, Ferri R, Gigli GL, Petrella MA, et al: Fragile-X syndrome: a particular epileptogenic EEG pattern. Epilepsia 1988;29:41-47.
42. Boyd SG, Harden A, Patton MA: The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 1988;147:508-513.
43. Papavasiliou AS, Bazigou H, Paraskevou- lakos E, Kotsalis C: Neurometabolic test- ing in developmental delay. J Child Neu- rol 2000;15:620-622.